MORGAN R ANDREW 4
4 · BONE CARE INTERNATIONAL INC · Filed Jul 1, 2005
Insider Transaction Report
Form 4
MORGAN R ANDREW
VP-Reg Affairs
Transactions
- Disposition to Issuer
BCII Stock Option Plan
2005-07-01$29.60/sh−20,000$592,000→ 0 totalExercise: $3.40Exp: 2012-07-24→ BCII Common Stock (20,000 underlying) - Disposition to Issuer
BCII Restricted Stock Units
2005-07-01$33.00/sh−10,000$330,000→ 0 total - Disposition to Issuer
BCII Stock Option Plan
2005-07-01$11.88/sh−5,000$59,400→ 0 totalExercise: $21.12Exp: 2014-06-22→ BCII Common Stock (5,000 underlying) - Disposition to Issuer
BCII Common stock
2005-07-01$33.00/sh−65,000$2,145,000→ 0 total
Footnotes (3)
- [F1]Disposed of pursuant to agreement and plan of merger between issuer and Genzyme Corporation and Macbeth Corporation in exchange for a cash payment of $33.00 per share of BCII Common Stock.
- [F2]Disposed of pursuant to agreement and plan of merger between issuer and Genzyme Corporation and Macbeth Corporation in exchange for a cash payment of $33.00 per BCII Restricted Stock Unit.
- [F3]Each BCII Stock Option became exercisable in full upon consummation of the merger and was cancelled in the merger and was cancelled in the merger in exchange for a cash payment per share subject to the option equal to the difference between the exercise price of the option and $33.00.